Updated on 14 May 2012
They also plan to make kidney iPS cells from patients with inherited kidney diseases such as polycystic kidney disease and Alport disease. These cells in turn will provide human cell models to unmask how these diseases develop and search for drugs that can derail the process.
Melissa Little at the University of Queensland, while welcoming the step, said that, "This is an exciting development for this field of medicine. It opens the door to studies that may teach us about the nature of the problem in patients with kidney disease and screening for drugs that might help."